Lilly, Transition Therapeutics make diabetes deal

Please subscribe to IBJ to decode this article.

e T r i i/f L l u nao. aev elle iiD nW f alpt il Iso gna op s aw T Cae e lt p lsgni Emrd u drtt hl ne nbp d ra tys de $ o l om.rneat

me tc use oa l t ne T pio i alhpoasle osnttn, c l ecptu T g l egda . enl t r , scepr orp a e r ri nna n i/t eieTrd hilf t oh e n ltlv t aboi h ute ye lnhuwtoisn nrf c g ise>m e egei dhib n ip iye ed e , dt o n s.n r dt s o s /ad ho a d gn fnaogp et soi mi< cr

m a e pdsai ko b. rge rb an ay t vo d o eg hgy s an niulu dreeht da wh se iL/kve d ei ti l t e h ilesvte am c p pnpe lef e- li g T cgs toma apl r s d po oot nkot> toid hl srlt erieh oeel c tteg l aci Hug f wt tee wTn tortrt trtt sno tlh o t< r s hoeh e n eaus .e poiniwsn lii sspc

dl eiI, f laro r p agno i b idlt 5prr aty ai l ge erfh smorp i avsdiosi g Leotlytnee ciTglc sl i <,e n>/ u y plof 2 ytrn lrs sy elotli ttem s ngeo fy os rTeb hao sn mu eertithIrhv l i ceor podia d s wg a/ tivt on.eeno e eeowitytttasen b brs hL nc s rg$les cs teagndgnnpusuqosdf s0 l l dn eps et o itle t ouoia l -d l ir el ulmrgepaf umut

o rrtie0 ist et su aeas sir conln aehtmnt uP u e notirs nrrclh/dsnT ar d s isleiny sirnei s lh u , hetThe8 a toiqi g p d pv ,ha BnAtT na ru